Factors Associated With PASI90 Maintenance Without Flare-Up and Predictors of Biologics Discontinuation in Psoriasis: Two-Center Retrospective Cohort Study in Korea. [PDF]
Ann DermatolChoi MS +5 more
europepmc +1 more source
Safety of Risankizumab during Pregnancy in IBD. [PDF]
Inflamm Bowel DisTsur N +8 more
europepmc +1 more source
Background: The phase-4, IMMpulse study (NCT04908475) has demonstrated superior efficacy and safety of risankizumab compared to apremilast in systemic-eligible adult patients with moderate plaque psoriasis (1). Methods: At baseline, 118 patients received
Pinter, Andreas +9 more
core
Cost-Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan. [PDF]
Dermatol Ther (Heidelb)Igarashi A +6 more
europepmc +1 more source
Comparative Effectiveness of Four Biologics for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. [PDF]
CureusAbdullah A, Polus L.
europepmc +1 more source
Efficacy of Risankizumab in Moderate to Severe Psoriasis Considering Body Mass Index: A Scoping Review. [PDF]
CureusSarmiento K +6 more
europepmc +1 more source
Interleukin-23 Inhibitors in Inflammatory Bowel Disease. [PDF]
BioDrugsPuca P +8 more
europepmc +1 more source
Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab. [PDF]
Crohns Colitis 360Al Hosani M +12 more
europepmc +1 more source
Highlights of the 2026 European Crohn's and Colitis Conference: redefining the IBD care continuum. [PDF]
Crohns Colitis 360Al-Hindawi A +4 more
europepmc +1 more source
Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis. [PDF]
Dermatol Ther (Heidelb)Crowley J +11 more
europepmc +1 more source